
A unanimous U.S. Supreme Court on Thursday preserved widespread access to a popular medication abortion pill, the court’s first abortion-related decision since overturning Roe v. Wade two years ago.
After months of high-profile proceedings in the lower courts – at one point the medication, mifepristone, was on the verge of being pulled from the market entirely – the case ended in a judicial anticlimax. The justices dismissed the case on procedural grounds, ruling that the plaintiffs have not suffered the clear and concrete harms necessary, meaning they did not have the legal right, to bring the case in the first place.